Saip P - Search Results

1

Response evaluation of bone metastases in breast cancer: value of magnetic resonance imaging.

Saip P, Tenekeci N, Aydiner A, Dinçer M, Inanç S, Demir C, Oral EN, Topuz E. Saip P, et al. Cancer Invest. 1999;17(8):575-80. doi: 10.3109/07357909909032842. Cancer Invest. 1999. PMID: 10592764 Clinical Trial.

2

Intraperitoneal cisplatin--mitoxantrone in ovarian cancer patients with minimal residual disease.

Topuz E, Aydiner A, Saip P, Bengisu E, Berkman S, Disci R. Topuz E, et al. Among authors: saip p. Eur J Gynaecol Oncol. 1997;18(1):71-5. Eur J Gynaecol Oncol. 1997. PMID: 9061330 Clinical Trial.

3

Intraperitoneal cisplatin-mitoxantrone and intravenous ifosfamide combination as first-line treatment of ovarian cancer.

Topuz E, Saip P, Aydmer A, Salihoğlu Y, Berkman S, Bengisu E. Topuz E, et al. Among authors: saip p. Eur J Gynaecol Oncol. 1998;19(3):265-70. Eur J Gynaecol Oncol. 1998. PMID: 9641228 Clinical Trial.

4

Catheter complications associated with intraperitoneal chemotherapy.

Topuz E, Saip P, Aydiner A, Salihoglu Y, Aydin Y, Topuzlu C. Topuz E, et al. Among authors: saip p. Eur J Gynaecol Oncol. 1998;19(3):275-9. Eur J Gynaecol Oncol. 1998. PMID: 9641230

5

Investigation of the molecular changes during chemotherapy in non-Hodgkin's lymphoma.

Yazici H, Saip P, Inanç S, Onat H, Dalay N. Yazici H, et al. Among authors: saip p. Res Commun Mol Pathol Pharmacol. 1998 Jun;100(3):301-11. Res Commun Mol Pathol Pharmacol. 1998. PMID: 9730009 Clinical Trial.

6

Bcl-2 gene rearrangements and apoptosis rates in patients with non-Hodgkin's lymphoma during chemotherapy.

Yazici H, Yalcinkaya L, Inanc S, Onat H, Saip P, Dalay N. Yazici H, et al. Among authors: saip p. Clin Biochem. 1999 Feb;32(1):45-9. doi: 10.1016/s0009-9120(98)00085-x. Clin Biochem. 1999. PMID: 10074891 Clinical Trial.

7

Factors influencing the distribution of metastases and survival in extensive disease small cell lung cancer.

Tas F, Aydiner A, Topuz E, Camlica H, Saip P, Eralp Y. Tas F, et al. Among authors: saip p. Acta Oncol. 1999;38(8):1011-5. doi: 10.1080/028418699432275. Acta Oncol. 1999. PMID: 10665754

8

Celsite port and catheter as an intraperitoneal access device in the treatment of ovarian cancer.

Topuz E, Salihoglu Y, Aydiner A, Saip P, Tas F, Sozen T, Berkman S, Bengisu E. Topuz E, et al. Among authors: saip p. J Surg Oncol. 2000 Jul;74(3):223-6. doi: 10.1002/1096-9098(200007)74:3<223::aid-jso14>3.0.co;2-q. J Surg Oncol. 2000. PMID: 10951423 Clinical Trial.

9

BRCA1 and BRCA2 mutations in Turkish breast/ovarian families and young breast cancer patients.

Yazici H, Bitisik O, Akisik E, Cabioglu N, Saip P, Muslumanoglu M, Glendon G, Bengisu E, Ozbilen S, Dincer M, Turkmen S, Andrulis IL, Dalay N, Ozcelik H. Yazici H, et al. Among authors: saip p. Br J Cancer. 2000 Sep;83(6):737-42. doi: 10.1054/bjoc.2000.1332. Br J Cancer. 2000. PMID: 10952777 Free PMC article.

10

Angiogenesis and p53 protein expression in breast cancer: prognostic roles and interrelationships.

Tas F, Yavuz E, Aydiner A, Saip P, Disci R, Iplikci A, Topuz E. Tas F, et al. Among authors: saip p. Am J Clin Oncol. 2000 Dec;23(6):546-53. doi: 10.1097/00000421-200012000-00002. Am J Clin Oncol. 2000. PMID: 11202793

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

118 results

Search Page

Filters